# A Study to Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF Therapy

> **NCT00679445** · PHASE2 · COMPLETED · sponsor: **NeoVista** · enrollment: 20 (estimated)

## Conditions studied

- Wet Age-related Macular Degeneration

## Interventions

- **DEVICE:** NeoVista Ophthalmic System

## Key facts

- **NCT ID:** NCT00679445
- **Lead sponsor:** NeoVista
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2011-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00679445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00679445, "A Study to Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF Therapy". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT00679445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*